(Q34086076)

30 July 2017

1 reference

title

Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction (English)

1 reference

30 July 2017

Rothman RB

1

1 reference

30 July 2017

Partilla JS

2

1 reference

30 July 2017

Dersch CM

3

1 reference

30 July 2017

Carroll FI

4

1 reference

30 July 2017

Rice KC

5

1 reference

30 July 2017

Baumann MH

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Annals of the New York Academy of Sciences

30 July 2017

published in

1 reference

30 July 2017

volume

914

1 reference

30 July 2017

page(s)

71-81

1 reference

Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Neurochemical changes in cocaine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Neurochemical correlates of cocaine and ethanol self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Hypothesis that mesolimbic dopamine (DA) plays a key role in mediating the reinforcing effects of drugs of abuse as well as the rewarding effects of ingestive behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Phentermine and Fenfluramine: Preclinical Studies in Animal Models of Cocaine Addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Opposite effects of stress on dopamine release in the limbic system of drug-naive and chronically amphetamine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Amphetamine and fenfluramine suppress ethanol intake in ethanol-dependent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Combined serotonin and dopamine indirect agonists correct alcohol craving and alcohol-associated neuroses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Treatment of alcohol and cocaine addiction by the combination of pemoline and fenfluramine: a preliminary case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Neurotoxic amphetamine analogues: effects in monkeys and implications for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05185.X

10.1111/J.1749-6632.2000.TB05185.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference